bRIGHT study 1-year data card
Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.
Related Resources
TAVI Summit 2023: Morphology
Navitor™: Voice of the Experts Nicolas Van Mieghem
TAVI Summit - TAVR in bicuspid
TAVI 2023: The next level
Tendyne™: Animation
Navitor™: Voice of the Experts Federico de Marco
PCR London Valves 2022 – Treatment of Mitral Valve disease
M-TEER: patient selection and current evidence
TRENDING TOPICS
EACTS 2024 - Novel approaches for Valvular and LVAD therapies
Early outcomes on Epic Max platform
Transfemoral TAVI
